Osaic Holdings
VIR icon

Osaic Holdings’s Vir Biotechnology VIR Stock Holding History

Osaic Holdings’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.5K Buy
4,168
+924
+28% +$8.79K ﹤0.01% 5596
2026
Q1 		$29.1K Sell
3,244
-1,115
-26% -$8.88K ﹤0.01% 5602
2025
Q4 		$26.3K Sell
4,359
-1,122
-20% -$6.68K ﹤0.01% 5678
2025
Q3 		$30.2K Sell
5,481
-28
-0.5% -$143 ﹤0.01% 5651
2025
Q2 		$27.8K Buy
5,509
+1,627
+42% +$8.72K ﹤0.01% 5461
2025
Q1 		$25.2K Buy
3,882
+547
+16% +$4.86K ﹤0.01% 5201
2024
Q4 		$24.5K Sell
3,335
-236
-7% -$1.86K ﹤0.01% 5206
2024
Q3 		$26.7K Buy
3,571
+801
+29% +$6.96K ﹤0.01% 5184
2024
Q2 		$24.7K Sell
2,770
-113
-4% -$1.08K ﹤0.01% 5190
2024
Q1 		$29.2K Buy
2,883
+882
+44% +$8.98K ﹤0.01% 5117
2023
Q4 		$20.1K Sell
2,001
-633
-24% -$5.78K ﹤0.01% 5494
2023
Q3 		$24.7K Sell
2,634
-146
-5% -$2.08K ﹤0.01% 5432
2023
Q2 		$67.9K Buy
2,780
+434
+18% +$10.9K ﹤0.01% 4740
2023
Q1 		$54.8K Sell
2,346
-220
-9% -$5.63K ﹤0.01% 4884
2022
Q4 		$65.2K Sell
2,566
-1,192
-32% -$29.2K ﹤0.01% 4740
2022
Q3 		$73K Buy
3,758
+2,500
+199% +$63.6K ﹤0.01% 4619
2022
Q2 		$32K Sell
1,258
-6,848
-84% -$160K ﹤0.01% 5298
2022
Q1 		$262K Sell
8,106
-1,720
-18% -$51K ﹤0.01% 3792
2021
Q4 		$397K Buy
9,826
+846
+9% +$33.1K ﹤0.01% 3288
2021
Q3 		$343K Buy
8,980
+1,549
+21% +$67.1K ﹤0.01% 3405
2021
Q2 		$330K Buy
7,431
+22
+0.3% +$1K ﹤0.01% 3425
2021
Q1 		$371K Sell
7,409
-12,101
-62% -$652K ﹤0.01% 3183
2020
Q4 		$523K Buy
19,510
+17,962
+1,160% +$584K ﹤0.01% 2601
2020
Q3 		$54K Sell
1,548
-1,322
-46% -$56.9K ﹤0.01% 4249
2020
Q2 		$117K Buy
2,870
+70
+3% +$2.35K ﹤0.01% 3581
2020
Q1 		$96K Buy
+2,800
New +$75.3K ﹤0.01% 3505

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Osaic Holdings's VIR Position: Q2 2026 in Review

Osaic Holdings increased its Vir Biotechnology (VIR) stake by 28% in Q2 2026, buying an estimated $8.79K and bringing the position to 4,168 shares worth $42.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5596.

Osaic Holdings first reported a position in VIR in Q1 2020 and has held it in 26 quarters since. The position peaked at $523K in Q4 2020. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Osaic Holdings held 4,168 shares of Vir Biotechnology worth $42.5K as of Q2 2026.
  • Osaic Holdings bought 924 Vir Biotechnology shares in Q2 2026, an estimated $8.79K.
  • Vir Biotechnology made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5596 holding.
  • Osaic Holdings first reported a position in Vir Biotechnology in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Vir Biotechnology position peaked at $523K in Q4 2020.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.